353 related articles for article (PubMed ID: 20665447)
1. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
2. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
3. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
4. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
5. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
6. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
7. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
[TBL] [Abstract][Full Text] [Related]
8. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
10. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
11. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.
Skyba P; Kluchova Z; Joppa P; Petrasova D; Tkacova R
Med Sci Monit; 2009 Oct; 15(10):CR528-533. PubMed ID: 19789512
[TBL] [Abstract][Full Text] [Related]
12. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
13. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
Ju CR; Chen RC
Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables.
Comeche Casanova L; Echave-Sustaeta JM; García Luján R; Albarrán Lozano I; Alonso González P; Llorente Alonso MJ
Arch Bronconeumol; 2013 Sep; 49(9):383-7. PubMed ID: 23791383
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
[TBL] [Abstract][Full Text] [Related]
17. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
18. Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease.
Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Karwat K; Nejman-Gryz P; Chazan R
Pneumonol Alergol Pol; 2015; 83(2):120-5. PubMed ID: 25754053
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation and metabolic syndrome in stable COPD patients.
Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
[TBL] [Abstract][Full Text] [Related]
20. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
